Harmony Biosciences Holdings, Inc. (HRMY)
USD 33.48
(-0.45%)
USD 33.48
(-0.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 219.38 Million | 144.46 Million | 98.55 Million | -2.98 Million | -75.43 Million | -38.79 Million |
| Net Income | 128.85 Million | 181.46 Million | 34.59 Million | -36.94 Million | -151.97 Million | -39.89 Million |
| Depreciation & Amortization | 24.35 Million | 23.38 Million | 18.84 Million | 10.23 Million | 3.21 Million | 184 Thousand |
| Deferred income taxes | -13.41 Million | -85.94 Million | 26.14 Million | 25.74 Million | - | - |
| Stock-based compensation | 31.7 Million | 26.17 Million | 15.65 Million | 4.69 Million | 9.9 Million | 1.07 Million |
| Change in working capital | 35.03 Million | -4.1 Million | 631 Thousand | -11.62 Million | 8.29 Million | -164 Thousand |
| Other non-cash items | 12.85 Million | 3.48 Million | 2.68 Million | 4.9 Million | 55.13 Million | 2.05 Million |
| Investing Cash Flow | -46.43 Million | -141.83 Million | -100.29 Million | -2 Million | -127.14 Million | -1.34 Million |
| Investments in PPE | -312 Thousand | -40.17 Million | -100.29 Million | -2 Million | -127.14 Million | -1.34 Million |
| Acquisitions | -36.96 Million | 141.83 Million | -100 Million | -2 Million | -52 Million | - |
| Investment purchases | -127.46 Million | -110.72 Million | - | - | - | - |
| Sales/Maturities of investments | 118.3 Million | 9.06 Million | - | - | - | - |
| Other Investing Activities | -9.16 Million | -141.83 Million | 100 Million | 2 Million | 52 Million | - |
| Financing Cash Flow | -105.55 Million | 6.84 Million | 7.41 Million | 209.16 Million | 143.76 Million | 21.61 Million |
| Debt repayment | -10.09 Million | -2 Million | -222.5 Million | -120.58 Million | -94.81 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -100 Million | - | - | -167 Thousand | -1.13 Million | -3.2 Million |
| Common Stock Issuance | 5.05 Million | 8.84 Million | 30 Million | 147.62 Million | 50.08 Million | 25 Million |
| Other Financing Activities | -514 Thousand | 6.84 Million | 199.91 Million | 382.58 Million | 333.4 Million | 24.81 Million |
| Accounts receivables | -19.4 Million | -19.89 Million | -12.66 Million | -17.92 Million | -4.25 Million | - |
| Accounts payables | 8.94 Million | 2.78 Million | -1.55 Million | -3.8 Million | 4.89 Million | -610 Thousand |
| Inventory | -1.06 Million | 135 Thousand | -609 Thousand | -2.73 Million | -1.08 Million | - |
| Other working capital | 46.55 Million | 12.87 Million | 15.46 Million | 12.83 Million | 8.73 Million | 446 Thousand |
| Cash at beginning of period | 244.53 Million | 235.05 Million | 229.38 Million | 25.2 Million | 84.02 Million | 102.54 Million |
| Cash at end of period | 311.93 Million | 244.53 Million | 235.05 Million | 229.38 Million | 25.2 Million | 84.02 Million |
| Capital Expenditure | -312 Thousand | -40.17 Million | -100.29 Million | -2 Million | -127.14 Million | -1.34 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 67.39 Million | 9.47 Million | 5.67 Million | 204.17 Million | -58.81 Million | -18.52 Million |
| Free Cash Flow | 219.07 Million | 104.29 Million | -1.74 Million | -4.98 Million | -202.58 Million | -40.14 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 46.09 Million | 11.59 Million | 38.33 Million | 26.6 Million | 128.85 Million | 38.46 Million |
| Depreciation & Amortization | 5.96 Million | 6.05 Million | 6.12 Million | 6.12 Million | 24.35 Million | 6.1 Million |
| Deferred income taxes | -4.83 Million | -14.27 Million | -3.47 Million | 1.12 Million | -13.41 Million | -6.9 Million |
| Stock-based compensation | 11.04 Million | 11.08 Million | 10.39 Million | 8.86 Million | 31.7 Million | 7.99 Million |
| Change in working capital | 11.7 Million | -14.51 Million | -20.32 Million | 31.64 Million | 35.03 Million | 6.72 Million |
| Other non-cash items | 518 Thousand | 62.95 Million | 31.39 Million | 2.3 Million | 12.85 Million | 10.72 Million |
| Investing Cash Flow | 745 Thousand | -54.85 Million | -6.18 Million | -36.06 Million | -46.43 Million | -813 Thousand |
| Investments in PPE | -3000.00 | -632 Thousand | -5000.00 | -107 Thousand | -312 Thousand | - |
| Acquisitions | - | -33.06 Million | - | -44.53 Million | -36.96 Million | - |
| Investment purchases | -23.28 Million | -21.21 Million | -25.1 Million | -21.61 Million | -127.46 Million | -33 Million |
| Sales/Maturities of investments | 24.03 Million | 25.55 Million | 18.92 Million | 22.62 Million | 118.3 Million | 32.19 Million |
| Other Investing Activities | - | -25.5 Million | -6.18 Million | 7.56 Million | -9.16 Million | -813 Thousand |
| Financing Cash Flow | -1.17 Million | -3.44 Million | -3.63 Million | -53.52 Million | -105.55 Million | -55.09 Million |
| Debt repayment | -3.75 Million | -3.75 Million | -3.75 Million | -3.75 Million | -10.09 Million | -5.34 Million |
| Dividends payments | - | - | - | -55.26 Million | - | - |
| Common Stock Repurchased | 269 Thousand | -269 Thousand | - | -50 Million | -100 Million | -50 Million |
| Common Stock Issuance | -689 Thousand | 573 Thousand | 116 Thousand | 227 Thousand | 5.05 Million | 244 Thousand |
| Other Financing Activities | 2.57 Million | -269 Thousand | 116 Thousand | 196.5 Million | -514 Thousand | -205.34 Million |
| Accounts receivables | 1.65 Million | -3.43 Million | -5.57 Million | -6.87 Million | -19.4 Million | -3.45 Million |
| Accounts payables | -12.15 Million | 6.14 Million | -2.58 Million | 6.19 Million | 8.94 Million | -24 Thousand |
| Inventory | -1.27 Million | 214 Thousand | -494 Thousand | -276 Thousand | -1.06 Million | -233 Thousand |
| Other working capital | 23.47 Million | -17.43 Million | -11.66 Million | 32.6 Million | 46.55 Million | 10.43 Million |
| Cash at beginning of period | 317.56 Million | 332.98 Million | 311.66 Million | 324.85 Million | 244.53 Million | 317.66 Million |
| Cash at end of period | 387.63 Million | 317.29 Million | 332.98 Million | 311.93 Million | 311.93 Million | 324.85 Million |
| Capital Expenditure | -3000.00 | -632 Thousand | -5000.00 | -107 Thousand | -312 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 70.07 Million | -15.68 Million | 21.32 Million | -12.92 Million | 67.39 Million | 7.18 Million |
| Free Cash Flow | 70.49 Million | 41.98 Million | 31.13 Million | 76.55 Million | 219.07 Million | 63.1 Million |
ZIONP
LNA
DUNIY
SHRIPISTON
BBL
USHA